{"nct_id":"NCT04592653","title":"Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-01","start_date":"2020-09-30","start_date_type":"ACTUAL","primary_completion_date":"2024-07","primary_completion_date_type":"ESTIMATED","completion_date":"2024-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MURA"]}